• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[抗结核化疗]

[Antitubercular chemotherapy].

作者信息

Jouveshomme S, Dautzenberg B

机构信息

Service de Pneumologie et Réanimation Respiratoire, Groupe Hospitalier Pitié-Salpêtrière, Paris.

出版信息

Rev Mal Respir. 1997 Dec;14 Suppl 5:S88-104.

PMID:9496594
Abstract

Treatment of tuberculosis has three major goals: healing the patient, preventing selection of resistant strains and control transmission of tuberculosis. A 6 month regimen consisting of isoniazid, rifampin with addition of pyrazinamide for 2 months is the preferred treatment for pulmonary and extra-pulmonary tuberculosis. If resistance to isoniazid is suspected, ethambutol should be added until drug susceptibility studies become available. This treatment is effective in both HIV infected and uniinfected persons. Treatment failure is mostly related to lack of patient adherence to the drug regimen and to multidrug-resistant tuberculosis. The treatment of multidrug-resistant tuberculosis requires second line drugs which are less effective and poorly tolerated. Prevention of resistant tuberculosis needs adequate treatment of each case of tuberculosis and improving of the patient compliance.

摘要

结核病治疗有三个主要目标

治愈患者、防止耐药菌株的产生以及控制结核病的传播。由异烟肼、利福平组成的6个月疗程,并加用吡嗪酰胺2个月,是治疗肺结核和肺外结核的首选方案。如果怀疑对异烟肼耐药,应加用乙胺丁醇,直至获得药敏试验结果。这种治疗方法对感染和未感染HIV的患者均有效。治疗失败主要与患者未坚持用药方案以及耐多药结核病有关。耐多药结核病的治疗需要使用二线药物,这些药物疗效较差且耐受性不佳。预防耐药结核病需要对每一例结核病患者进行充分治疗,并提高患者的依从性。

相似文献

1
[Antitubercular chemotherapy].[抗结核化疗]
Rev Mal Respir. 1997 Dec;14 Suppl 5:S88-104.
2
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.成人及儿童结核病和结核感染的治疗。美国胸科学会。
Monaldi Arch Chest Dis. 1994 Sep;49(4):327-45.
3
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.耐多药肺结核12个月治疗方案的结果
Int J Tuberc Lung Dis. 2002 Dec;6(12):1102-9.
4
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.在结核病短程化疗期间,因依从性差而产生耐药性的情况。
Int J Tuberc Lung Dis. 1998 Jan;2(1):10-5.
5
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.采用异烟肼、利福平、乙胺丁醇和吡嗪酰胺治疗耐异烟肼结核病6个月。
Int J Tuberc Lung Dis. 2002 Nov;6(11):952-8.
6
Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.印度古吉拉特邦既往治疗过的结核病患者的耐药性研究。
Int J Tuberc Lung Dis. 2002 Dec;6(12):1098-101.
7
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.采用标准化短程化疗“成功”治疗的耐多药结核病病例的复发频率。
Int J Tuberc Lung Dis. 2002 Oct;6(10):858-64.
8
[Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].[耐异烟肼或耐利福平结核病的特征及治疗结果]
Kekkaku. 2003 Oct;78(10):611-7.
9
[Short-term therapy of lung tuberculosis using a fixed combination of isoniazid, rifampicin and pyrazinamide. Results after 2 years].[使用异烟肼、利福平与吡嗪酰胺固定组合进行肺结核的短期治疗。2年后的结果]
Schweiz Med Wochenschr. 1989 Mar 11;119(10):299-305.
10
[Drug-resistant pulmonary tuberculosis at the penitentiaries].[监狱中的耐多药肺结核]
Probl Tuberk Bolezn Legk. 2008(12):60-3.